Journal Article: Are manufacturing patents to blame for biosimilar market launch delays?
Williamson, Rhys, Munro, Trent, Robertson, Avril, Pregelj, Lisette and Ascher, David (2023). Are manufacturing patents to blame for biosimilar market launch delays?. Value in Health. doi: 10.1016/j.jval.2023.12.005
Journal Article: Delivering impactful solutions for the bioeconomy
Hankamer, Ben, Pregelj, Lisette, O’Kane, Shane, Hussey, Karen and Hine, Damian (2023). Delivering impactful solutions for the bioeconomy. Trends in Plant Science, 28 (5), 583-596. doi: 10.1016/j.tplants.2023.02.007
Journal Article: Restoring Australia’s long-term innovation requires investment in basic research
Harrison, Rosemary S., Barnard, Ross T. and Pregelj, Lisette (2023). Restoring Australia’s long-term innovation requires investment in basic research. Microbiology Australia, 44 (1), 57-61. doi: 10.1071/ma23014
Adaptive Coordination In the Digital Health Industry: Maintaining Australia's Global Competitiveness
(2018–2020) MTPConnect
(2015–2018) UQ Postdoctoral Research Fellowship
Development of the algae sector through business model innovation
Doctor BioTechnology
Entrepreneurial orientation, learning orientation, and innovation capability in the creative industry performance
Doctor Philosophy
Biosimilar litigation and market entry
Doctor Philosophy
Hine, Damian, Pregelj, Lisette and McManus, Michael (2018). Commercializing university research to mitigate simultaneous change stimuli: an exemplar case from the Australian higher education sector. World scientific reference on innovation. (pp. 97-112) edited by Donald Siegel. Singapore: World Scientific . doi: 10.1142/9789813149045_0006
Pregelj, Lisette, Verreynne, Martie-Louise and Hine, Damian (2011). Small pharmaceutical firms building capabilities to compete along the global research and development pipeline. International entrepreneurship in the life sciences. (pp. 64-100) edited by Marian V. Jones, Colin Wheeler and Pavlos Dimitratos. Cheltenham United Kingdom: Edward Elgar Publishing.
Are manufacturing patents to blame for biosimilar market launch delays?
Williamson, Rhys, Munro, Trent, Robertson, Avril, Pregelj, Lisette and Ascher, David (2023). Are manufacturing patents to blame for biosimilar market launch delays?. Value in Health. doi: 10.1016/j.jval.2023.12.005
Delivering impactful solutions for the bioeconomy
Hankamer, Ben, Pregelj, Lisette, O’Kane, Shane, Hussey, Karen and Hine, Damian (2023). Delivering impactful solutions for the bioeconomy. Trends in Plant Science, 28 (5), 583-596. doi: 10.1016/j.tplants.2023.02.007
Restoring Australia’s long-term innovation requires investment in basic research
Harrison, Rosemary S., Barnard, Ross T. and Pregelj, Lisette (2023). Restoring Australia’s long-term innovation requires investment in basic research. Microbiology Australia, 44 (1), 57-61. doi: 10.1071/ma23014
Pregelj, Lisette, Hine, Damian C., Kesselheim, Aaron S. and Darrow, Jonathan J. (2021). Assessing the Impact of US Food and Drug Administration Breakthrough Therapy designation timing on trial characteristics and development speed. Clinical Pharmacology and Therapeutics, 110 (4) cpt.2318, 1018-1024. doi: 10.1002/cpt.2318
Working hard or hardly working? Regulatory bottlenecks in developing a COVID-19 vaccine
Pregelj, Lisette, Hine, Damian C., Oyola-Lozada, Maria G. and Munro, Trent P. (2020). Working hard or hardly working? Regulatory bottlenecks in developing a COVID-19 vaccine. Trends in Biotechnology, 38 (9), 943-947. doi: 10.1016/j.tibtech.2020.06.004
Precision medicines have faster approvals based on fewer and smaller trials than other medicines
Pregelj, Lisette, Hwang, Thomas J., Hine, Damian C., Siegel, Evan B., Barnard, Ross T., Darrow, Jonathan J. and Kesselheim, Aaron S. (2018). Precision medicines have faster approvals based on fewer and smaller trials than other medicines. Health affairs (Project Hope), 37 (5), 724-731. doi: 10.1377/hlthaff.2017.1580
Changes in clinical trial length
Pregelj, Lisette, Verreynne, Martie-Louise and Hine, Damian (2015). Changes in clinical trial length. Nature Reviews Drug Discovery, 14 (5), 307-308. doi: 10.1038/nrd4611
Deconstructing and reconstructing the capability hierarchy
Hine, Damian, Parker, Rachel, Pregelj, Lisette and Verreynne, Martie-Louise (2013). Deconstructing and reconstructing the capability hierarchy. Industrial and Corporate Change, 23 (5), 1299-1325. doi: 10.1093/icc/dtt046
Pregelj, Lisette, McLanders, Joanne R., Gresshoff, Peter M. and Schenk, Peer M. (2011). Transcription profiling of the isoflavone phenylpropanoid pathway in soybean in response to Bradyrhizobium japonicum inoculation. Functional Plant Biology, 38 (1), 13-24. doi: 10.1071/FP10093
Pongamia pinnata : An Untapped Resource for the Biofuels Industry of the Future
Scott, Paul T., Pregelj, Lisette, Chen, Ning, Hadler, Johanna S., Djordjevic, Michael A. and Gresshoff, Peter M. (2008). Pongamia pinnata : An Untapped Resource for the Biofuels Industry of the Future. Bioenergy Research, 1 (1), 2-11. doi: 10.1007/s12155-008-9003-0
Capability development in the pharmaceutical commercialisation process
Pregelj, Lisette, Verreynne, Martie-Louise and Hine, Damian (2011). Capability development in the pharmaceutical commercialisation process. 14th Asia-Pacific Researchers in Organization Studies Conference (APROS 2011), Auckland, New Zealand, 28 November - 1 December 2011. Auckland, New Zealand: Auckland University of Technology.
Capability building in the pharmaceutical industry
Hine, D., Pregelj, L. and Verreynne, M. (2010). Capability building in the pharmaceutical industry. Strategic Management Society Conference, Rome, Italy, 12-15 September, 2010.
Speeding up drug development: Productivity and innovation speed in the biosciences
Pregelj, Lisette, Verreynne, Martie-Louise and Hine, Damian (2010). Speeding up drug development: Productivity and innovation speed in the biosciences. AGSE Entrepreneurship Conference, Sunshine Coast, QLD, Australia, 3-5 February 2010. Hawthorn, VIC, Australia: The Australian Graduate School of Entrepreneurship, Swinburne University of Technology.
Functional genomics of the regulation of nodule number in legumes
Gresshoff, PM, Gualtieri, G, Laniya, T, Indrasumunar, A, Miyahara, A, Nontachaiyapoom, S, Wells, T, Biswas, B, Chan, PK, Scott, P, Kinkema, M, Djordjevic, M, Hoffmann, D, Pregelj, L, Buzas, DM, Li, DX, Men, A, Jiang, Q, Hwang, CH and Carroll, BJ (2005). Functional genomics of the regulation of nodule number in legumes. 14th International Nitrogen Fixation Congress, Beijing, China, 27 October - 1 November 2004. The Netherlands: Springer. doi: 10.1007/1-4020-3570-5
Functional genomics of the regulation of nodule number in legumes
Gresshoff, Peter M., Gualtieri, Gustavo, Laniya, Titeki, Indrasumunar, Arief, Miyahara, Akira, Nontachaiyapoom, Sureeporn, Wells, Tim, Biswas, Bandana, Chan, Pick Kuen, Scott, Paul, Kinkema, M., Djordjevic, M., Hoffmann, Dana, Pregelj, Lisette, Buzas, Diana M., Li, Dong Xi, Men, Artem, Jiang, Qunyi, Hwang, Cheol-Ho and Carroll, Bernard J. (2005). Functional genomics of the regulation of nodule number in legumes. 14th International Nitrogen Fixation Congress, Beijing, China, 27 October - 1 November 2004. Dordrecht, Netherlands: Springer Netherlands. doi: 10.1007/1-4020-3570-5_41
Functional genomic analysis of nodule development in soybean and Lotus Japonicus
Gresshoff, P. M., Carroll, B. J., Gualtieri Gonzalez, G. S., Vickers, C., Kuen, P., Huang, C., Scott, P. T., Kinkema, M. D., Men, A., Stiller, J., Jiang, Q., Laniya, T.S., Buzas, D. M., Miyahara, A., Indrasumunar, A., Nontachaiyapoom, S., Hoffmann, D., Biswas, B., Wells, T. J., So, H., Pregelj, L. and Dong, X. (2004). Functional genomic analysis of nodule development in soybean and Lotus Japonicus. Com Bio 2004, Intercontinental Burswood Resort, Perth, Australia, 26-30 September, 2004.
Oyola Lozada, Giuliana, Jenkins, Anna, Pregelj, Lisette and MacAulay, Sam (2022). Interviews. The University of Queensland. (Dataset) doi: 10.48610/4ef737d
Capability development along the capability lifecycle: Evidence from the pharmaceutical industry
Pregelj, Lisette (2013). Capability development along the capability lifecycle: Evidence from the pharmaceutical industry. PhD Thesis, UQ Business School, The University of Queensland.
Steen, John, Verreynne, Martie-Louise, Pregelj, Lisette, Foster, Mishka and Cretchley, Julia (2012). Brisbane Innovation Scorecard 2012. Brisbane City Council and Brisbane Marketing Economic Development Board. Brisbane, Australia:
Adaptive Coordination In the Digital Health Industry: Maintaining Australia's Global Competitiveness
(2018–2020) MTPConnect
(2015–2018) UQ Postdoctoral Research Fellowship
Development of the algae sector through business model innovation
Doctor BioTechnology — Principal Advisor
Entrepreneurial orientation, learning orientation, and innovation capability in the creative industry performance
Doctor Philosophy — Principal Advisor
Other advisors:
Biosimilar litigation and market entry
Doctor Philosophy — Principal Advisor
Other advisors:
Disruptive innovation: How can it be valued and priced? A case of novel theranostics in oncology
Doctor Philosophy — Associate Advisor
Other advisors:
(2020) Doctor BioTechnology — Associate Advisor
Other advisors: